Form D · Other
NJ BIO, Inc.
Princeton, NJ · CIK 0001968755
Offering snapshot reported Mar 9, 2023 · SEC filing
- Reported sold
- $5.62M Offering amount: $7.84M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 22, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 9, 2023 | Initial | $5,621,204 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-475322
Source: Form D, filed Mar 9, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ronald Gold | Director |
| Anjanish Gondalia | Director |
| Chetan Jain | Director |
| Nareshkumar Jain | Director, Executive |
| Steven Klosk | Director |
| Priyashri Nayak | Director |
Issuer details
Industry: Other (See others in industry)
Address:
350 Carter Road
Princeton, NJ, 08540
Princeton, NJ, 08540